tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Welford, 26 are a BUY (59.09%), 13 are a HOLD (29.55%), 5 are a SELL (11.36%).
Analyst Peter Welford, currently employed at JEFFERIES, carries an average stock price target met ratio of 45.63% that have a potential upside of 25.24% achieved within 322 days.
Peter Welford’s has documented 81 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 02-Jul-2024.
Analyst best performing recommendations are on CGEN (COMPUGEN).
The best stock recommendation documented was for PLX (PROTALIX BIOTHERAPEUTICS) at 9/6/2016. The price target of $8 was fulfilled within 156 days with a profit of $1.8 (29.03%) receiving and performance score of 1.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
95
$7.38 (8.42%)
66
19 days ago
6/7 (85.71%)
$12.48 (15.12%)
360
Buy
85
$-2.62 (-2.99%)
80
3 months 1 days ago
4/4 (100%)
$8.23 (10.72%)
390
Buy
82
$-5.62 (-6.41%)
80
4 months 5 days ago
4/4 (100%)
$6.83 (9.09%)
296
Hold
6 months 23 days ago
1/11 (9.09%)
$82.61 (131.40%)
2587
Buy
85
$-2.62 (-2.99%)
7 months 8 days ago
1/11 (9.09%)
$19.26 (29.30%)
210
Which stock is Peter Welford is most bullish on?
Which stock is Peter Welford is most reserved on?
What Year was the first public recommendation made by Peter Welford?
